Results 31 to 40 of about 4,067,843 (298)

Cost-parity and cost-Streett games [PDF]

open access: yesFST&TCS, 2012
We consider two-player games played on finite graphs equipped with costs on edges and introduce two winning conditions, cost-parity and cost-Streett, which require bounds on the cost between requests and their responses. Both conditions generalize the corresponding classical ω-regular conditions as well as the corresponding finitary conditions.
Nathanaël Fijalkow   +1 more
openaire   +4 more sources

Innovation in the pharmaceutical industry: New estimates of R&D costs.

open access: yesJournal of Health Economics, 2016
The research and development costs of 106 randomly selected new drugs were obtained from a survey of 10 pharmaceutical firms. These data were used to estimate the average pre-tax cost of new drug and biologics development.
J. DiMasi, H. Grabowski, R. Hansen
semanticscholar   +1 more source

Evidence‐Based Clinical Practice Guidelines for the Management of Pediatric Febrile Neutropenia: Resource‐Sensitive Recommendations for the Asian Continent

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Febrile neutropenia (FN) is a frequent and serious complication in children receiving cancer therapy. Standardizing FN management across Asia is challenging due to variable healthcare infrastructure, diagnostic capacity, and infection patterns; however, it could improve resource use and patient outcomes.
Joliza Patricia Cañeba   +29 more
wiley   +1 more source

Nota Editorial

open access: yesCostos y Gestión, 2020
Nota ...
Regina Durán
doaj   +2 more sources

¿CONVIENE TRASLADAR A PRECIOS LA REDUCCIÓN DE COSTOS VARIABLES PARA APROVECHAR CAPACIDAD OCIOSA?

open access: yesCostos y Gestión, 2021
El artículo estudia los casos de empresas poliproductoras con restrictores comunes que estuvieren operando en óptimos de mercado con desaprovechamiento de capacidad productiva y/o comercial, focalizándose en proyectos de optimización de costos variables
Daniel Farré, Laura Ghezzi
doaj   +1 more source

Bone and Soft Tissue Neoplasms in Infants Versus Older Children: A Report From the Cancer in Young People in Canada Program

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Aims Infant bone and soft tissue neoplasms present distinct clinical challenges and lack large‐scale data to inform treatment decisions. This study aims to characterize bone and soft tissue neoplasms in infants in Canada and to compare their outcomes with those of older pediatric patients.
Samuel Sassine   +21 more
wiley   +1 more source

La teoría general de costo y la huella de carbono: en la búsqueda de un costo medio socialmente responsable

open access: yesCostos y Gestión, 2020
Las actividades económicas de las distintas cadenas productivas generan, desde su origen hasta el consumo final de los productos, emisión de gases que producen una huella ambiental que puede medirse y compensarse, pero que provocan un calentamiento ...
Gladys Ferraro   +2 more
doaj  

Negative emissions—Part 2: Costs, potentials and side effects

open access: yes, 2018
The most recent IPCC assessment has shown an important role for negative emissions technologies (NETs) in limiting global warming to 2 °C cost-effectively.
S. Fuss   +17 more
semanticscholar   +1 more source

Social costs of tourism during the COVID-19 pandemic

open access: yesAnnals of Tourism Research, 2020
The severe acute respiratory syndrome coronavirus 2 is currently spreading across the world at an alarming rate, resulting in the coronavirus disease 2019 pandemic.
Richard T. R. Qiu   +3 more
semanticscholar   +1 more source

Impact of Initial Treatment Setting on Survival in Relapsed Pediatric and AYA Bone Sarcomas: A Secondary Analysis of a Prospective Clinical Trial

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Outcomes in relapsed or refractory pediatric and AYA bone sarcomas remain poor, and the impact of early referral to specialized sarcoma centers on survival is unclear. Early centralization of care may improve local and systemic treatment quality, but evidence in this population is limited.
Justyna Antoniuk‐Majchrzak   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy